TY  - BOOK
TI  - Cardiovascular
SN  - 978-0-980825-38-1
U1  - 615.71 
PY  - 2012///
CY  - Australia
PB  - THERAPEUTIC GUIDELINES
KW  - DISLIPIDEMIA
KW  - SOBREPESO
KW  - TAQUIARRITMIAS
KW  - TRATAMIENTO FARMACOLÓGICO
KW  - 615.71 - Medicamentos que afectan a los sistemas cardiovascular y hematopoyético
N2  - Cardiovascular disease risk stratification. -- Behavioural risk factor modification. -- Adherence to drug therapy. -- Type 2 diabetes and cardiovascular disease risk. -- Overweight and obesity. -- Elevated blood pressure. – Dyslipidaemia. -- Coronary heart disease. -- Acute chest pain. -- Acute coronary syndromes. -- Ongoing management of patients with stable coronary artery disease. – Pericarditis. -- Heart failure. -- Acute management of arrhythmias. – Tachyarrhythmias. – Bradyarrhythmias. -- Treatment of deep vein thrombosis and pulmonary embolism. -- Prevention of venous thromboembolism. -- Peripheral arterial disease. -- Perioperative and periprocedural management of patients with cardiovascular disease. -- Antithrombotic therapy
ER  -